ArticleOrphanet journal of rare diseases2026
CCL14, identified by multi-omics approach, serves as a novel indicator of disease severity and progression in lymphangioleiomyomatosis.
Wenxue Bai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.